Psychedelic Drug Trends and Forecast
The future of the global psychedelic drug market looks promising with opportunities in the hospital and mental health center markets. The global psychedelic drug market is expected to reach an estimated $4.6 billion by 2030 with a CAGR of 12.4% from 2024 to 2030. The major drivers for this market are growing societal approval of psychedelic substances, escalation in the incidence of mental health disorders, and surge in funding for the exploration and advancement of psychedelic medications.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Psychedelic Drug by Segment
The study includes a forecast for the global psychedelic drug by drug type, application, end use, and region.
Psychedelic Drug Market by Drug Type [Shipment Analysis by Value from 2018 to 2030]:
• Ketamine
• Psilocybin
• Others
Psychedelic Drug Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Mental Health
• Abuse Disorder
• Others
Psychedelic Drug Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Mental Health Center
• Others
Psychedelic Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Psychedelic Drug Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies psychedelic drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the psychedelic drug companies profiled in this report include-
• Ceruvia Lifesciences
• Braxia Scientific
• Field Trip Health
• Apex Labs
• Numinus Wellness
• Johnson & Johnson
• Psyched Wellness
• Havn Life
• Enveric Biosciences
• PharmaTher
Psychedelic Drug Market Insights
Lucintel forecasts that mental health will remain the larger segment over the forecast period due to increase in the frequency of mental illnesses like post-traumatic disorder, anxiety, and depression.
Within this market, mental health center will remain the larger segment due to high use of psychedelic medications in this center to treat mental illness in mental health facilities.
North America is expected to witness highest growth over the forecast period due to rise in research and development to evaluate therapeutic effects of psychedelic drugs and presence of key players in the region.
Features of the Global Psychedelic Drug Market
Market Size Estimates: Psychedelic drug market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Psychedelic drug market size by drug type, application, end use, and region in terms of value ($B).
Regional Analysis: Psychedelic drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug types, applications, end uses, and regions for the psychedelic drug market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the psychedelic drug market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the psychedelic drug market size?
Answer: The global psychedelic drug market is expected to reach an estimated $4.6 billion by 2030.
Q2. What is the growth forecast for psychedelic drug market?
Answer: The global psychedelic drug market is expected to grow with a CAGR of 12.4% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the psychedelic drug market?
Answer: The major drivers for this market are growing societal approval of psychedelic substances, escalation in the incidence of mental health disorders, and surge in funding for the exploration and advancement of psychedelic medications.
Q4. What are the major segments for psychedelic drug market?
Answer: The future of the psychedelic drug market looks promising with opportunities in the hospital and mental health center markets.
Q5. Who are the key psychedelic drug market companies?
Answer: Some of the key psychedelic drug companies are as follows:
• Ceruvia Lifesciences
• Braxia Scientific
• Field Trip Health
• Apex Labs
• Numinus Wellness
• Johnson & Johnson
• Psyched Wellness
• Havn Life
• Enveric Biosciences
• PharmaTher
Q6. Which psychedelic drug market segment will be the largest in future?
Answer: Lucintel forecasts that mental health will remain the larger segment over the forecast period due to increase in the frequency of mental illnesses like post-traumatic disorder, anxiety, and depression.
Q7. In psychedelic drug market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to rise in research and development to evaluate therapeutic effects of psychedelic drugs and presence of key players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the psychedelic drug market by drug type (ketamine, psilocybin, and others), application (mental health, abuse disorder, and others), end use (hospitals, mental health center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Psychedelic Drug Market, Psychedelic Drug Market Size, Psychedelic Drug Market Growth, Psychedelic Drug Market Analysis, Psychedelic Drug Market Report, Psychedelic Drug Market Share, Psychedelic Drug Market Trends, Psychedelic Drug Market Forecast, Psychedelic Drug Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.